$50.7 Million is the total value of EMORY UNIVERSITY's 19 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 58.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKA | Sell | BERKSHIRE HATHAWAY INC DELcl a | $31,183,000 | -16.3% | 100 | -14.5% | 61.49% | +134.5% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $2,437,000 | -6.5% | 67,753 | -19.2% | 4.80% | +162.0% |
| THOR | Sell | SYNTHORX INC | $2,362,000 | +15.7% | 145,150 | -3.9% | 4.66% | +224.1% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,606,000 | -34.8% | 78,212 | -17.2% | 3.17% | +82.5% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $1,551,000 | -18.2% | 71,856 | -16.6% | 3.06% | +129.1% |
| RARX | Sell | RA PHARMACEUTICALS INC | $1,412,000 | -52.0% | 59,690 | -39.0% | 2.78% | +34.4% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $1,375,000 | -43.8% | 479,902 | -25.7% | 2.71% | +57.4% |
| MGTX | Sell | MEIRAGTX HOLDINGS PLC | $1,295,000 | -49.5% | 81,176 | -15.0% | 2.55% | +41.4% |
| ORTX | Sell | ORCHARD THERAPEUTICS PLCads | $1,291,000 | -25.2% | 108,692 | -11.9% | 2.55% | +109.5% |
| ZGNX | Sell | ZOGENIX INC | $997,000 | -65.2% | 24,890 | -58.5% | 1.97% | -2.4% |
| ACA | Sell | ARCOSA INC | $955,000 | -51.4% | 27,923 | -46.6% | 1.88% | +36.0% |
| HRTX | Sell | HERON THERAPEUTICS INC | $925,000 | -61.4% | 49,974 | -61.3% | 1.82% | +8.1% |
| RTRX | Sell | RETROPHIN INC | $895,000 | -64.0% | 77,180 | -37.6% | 1.76% | +1.0% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $762,000 | -52.7% | 146,475 | -17.7% | 1.50% | +32.5% |
| GHDX | Sell | GENOMIC HEALTH INC | $645,000 | -74.2% | 9,506 | -77.9% | 1.27% | -27.7% |
| SMLP | Sell | SUMMIT MIDSTREAM PARTNERS LP | $342,000 | -47.5% | 70,456 | -19.5% | 0.67% | +47.2% |
| COCP | COCRYSTAL PHARMA INC | $312,000 | -13.1% | 152,916 | 0.0% | 0.62% | +143.1% | |
| SPY | SPDR S&P 500 ETF TRtr unit | $280,000 | +1.4% | 942 | 0.0% | 0.55% | +184.5% | |
| IFRX | Sell | INFLARX NV | $91,000 | -50.8% | 36,818 | -37.0% | 0.18% | +37.7% |
| HD | Exit | HOME DEPOT INC | $0 | – | -1,819 | -100.0% | -0.27% | – |
| ADS | Exit | ALLIANCE DATA SYSTEMS CORP | $0 | – | -13,028 | -100.0% | -1.28% | – |
| SLM | Exit | SLM CORP | $0 | – | -190,827 | -100.0% | -1.31% | – |
| TRN | Exit | TRINITY INDS INC | $0 | – | -90,599 | -100.0% | -1.32% | – |
| MS | Exit | MORGAN STANLEY | $0 | – | -43,300 | -100.0% | -1.34% | – |
| KKR | Exit | KKR & CO INCcl a | $0 | – | -76,943 | -100.0% | -1.37% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -78,121 | -100.0% | -1.39% | – |
| STX | Exit | SEAGATE TECHNOLOGY PLC | $0 | – | -42,275 | -100.0% | -1.40% | – |
| CBRE | Exit | CBRE GROUP INCcl a | $0 | – | -39,052 | -100.0% | -1.41% | – |
| C | Exit | CITIGROUP INC | $0 | – | -28,938 | -100.0% | -1.43% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -39,349 | -100.0% | -1.46% | – |
| ASND | Exit | ASCENDIS PHARMA A Ssponsored adr | $0 | – | -18,334 | -100.0% | -1.49% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -17,807 | -100.0% | -1.55% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -26,278 | -100.0% | -1.58% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -33,593 | -100.0% | -1.64% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -18,235 | -100.0% | -1.68% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -192,533 | -100.0% | -1.69% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -90,188 | -100.0% | -1.70% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -23,131 | -100.0% | -1.71% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -28,714 | -100.0% | -1.72% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -29,020 | -100.0% | -1.72% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -132,255 | -100.0% | -1.80% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -27,551 | -100.0% | -1.83% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -30,680 | -100.0% | -2.22% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -131,041 | -100.0% | -2.26% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -86,567 | -100.0% | -2.82% | – |
| JD | Exit | JD COM INCspon adr cl a | $0 | – | -397,528 | -100.0% | -8.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
| 13F-HR | 2019-02-12 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.